[HTML][HTML] Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype
M Ohanna, Y Cheli, C Bonet, VF Bonazzi, M Allegra… - Oncotarget, 2013 - ncbi.nlm.nih.gov
Here, we showed that the secretome of senescent melanoma cells drives basal melanoma
cells towards a mesenchymal phenotype, with characteristic of stems illustrated by …
cells towards a mesenchymal phenotype, with characteristic of stems illustrated by …
Senescent cells develop a PARP-1 and nuclear factor-κB-associated secretome (PNAS)
M Ohanna, S Giuliano, C Bonet, V Imbert… - Genes & …, 2011 - genesdev.cshlp.org
Melanoma cells can enter the process of senescence, but whether they express a secretory
phenotype, as reported for other cells, is undetermined. This is of paramount importance …
phenotype, as reported for other cells, is undetermined. This is of paramount importance …
[HTML][HTML] Mitofusin 1 silencing decreases the senescent associated secretory phenotype, promotes immune cell recruitment and delays melanoma tumor growth after …
D Tarallo, J Martínez, A Leyva, A Mónaco, C Perroni… - Scientific Reports, 2024 - nature.com
Cellular senescence is a therapy endpoint in melanoma, and the senescence-associated
secretory phenotype (SASP) can affect tumor growth and microenvironment, influencing …
secretory phenotype (SASP) can affect tumor growth and microenvironment, influencing …
[HTML][HTML] IFN-γ and TNF induce senescence and a distinct senescence-associated secretory phenotype in melanoma
L Homann, M Rentschler, E Brenner, K Böhm… - Cells, 2022 - mdpi.com
Immune checkpoint blockade (ICB) therapy is a central pillar of melanoma treatment leading
to durable response rates. Important mechanisms of action of ICB therapy include …
to durable response rates. Important mechanisms of action of ICB therapy include …
Reshaping of the tumor microenvironment by cellular senescence: an opportunity for senotherapies
M D'Ambrosio, J Gil - Developmental Cell, 2023 - cell.com
Cellular senescence is a stress response associated with aging and disease, including
cancer. Senescent cells undergo a stable cell cycle arrest, undergo a change in morphology …
cancer. Senescent cells undergo a stable cell cycle arrest, undergo a change in morphology …
[HTML][HTML] Oncogenic senescence: a multi-functional perspective
DJ Baker, F Alimirah, JM van Deursen, J Campisi… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Cellular senescence is defined as an irreversible growth arrest with the acquisition of a
distinctive secretome. The growth arrest is a potent anticancer mechanism whereas the …
distinctive secretome. The growth arrest is a potent anticancer mechanism whereas the …
The role of cellular senescence and SASP in tumour microenvironment
M Takasugi, Y Yoshida, E Hara, N Ohtani - The FEBS journal, 2023 - Wiley Online Library
Cellular senescence refers to a state of irreversible cell cycle arrest that can be induced by
various cellular stresses and is known to play a pivotal role in tumour suppression. While …
various cellular stresses and is known to play a pivotal role in tumour suppression. While …
Targeting STAT3 affects melanoma on multiple fronts
M Kortylewski, R Jove, H Yu - Cancer and Metastasis Reviews, 2005 - Springer
As a point of convergence for numerous oncogenic signaling pathways, STAT3 is
constitutively-activated at 50 to 90% frequency in diverse human cancers, including …
constitutively-activated at 50 to 90% frequency in diverse human cancers, including …
Cellular senescence in the tumor microenvironment and context‐specific cancer treatment strategies
T Yasuda, H Baba, T Ishimoto - The FEBS Journal, 2023 - Wiley Online Library
Cellular senescence in cancer development is known to have tumor‐suppressive and tumor‐
promoting roles. Recent studies have revealed numerous molecular mechanisms of …
promoting roles. Recent studies have revealed numerous molecular mechanisms of …
[HTML][HTML] Enhancing chemotherapy efficacy by reprogramming the senescence-associated secretory phenotype of prostate tumors: A way to reactivate the antitumor …
A Toso, D Di Mitri, A Alimonti - Oncoimmunology, 2015 - Taylor & Francis
Senescent cells promote tumor clearance by evoking an antitumor immune response.
However in Pten-null prostate tumors treated with chemotherapy, the antitumor immune …
However in Pten-null prostate tumors treated with chemotherapy, the antitumor immune …